CD274 and cancer: Pharmacological blockade of the PD-1/PD-L1 interaction restores the anti-tumor immune response and represents one of the most promising therapy against cancer (Pardoll, 2012; Iwai et al., 2017; Sharpe and Pauken, 2018).